WO1994005637A1 - Optically active 1,4-dihydropyridine compound and process for producing the same - Google Patents
Optically active 1,4-dihydropyridine compound and process for producing the same Download PDFInfo
- Publication number
- WO1994005637A1 WO1994005637A1 PCT/JP1993/001222 JP9301222W WO9405637A1 WO 1994005637 A1 WO1994005637 A1 WO 1994005637A1 JP 9301222 W JP9301222 W JP 9301222W WO 9405637 A1 WO9405637 A1 WO 9405637A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- formula
- dimethyl
- optically active
- compound
- Prior art date
Links
- -1 1,4-dihydropyridine compound Chemical class 0.000 title claims description 37
- 238000000034 method Methods 0.000 title description 14
- 244000005700 microbiome Species 0.000 claims abstract description 22
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 6
- 230000007062 hydrolysis Effects 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 14
- 230000003287 optical effect Effects 0.000 claims description 11
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 4
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims description 3
- 125000004104 aryloxy group Chemical group 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 2
- MXOZDWUWLZHSFP-UHFFFAOYSA-N 2,6-dimethyl-4-(2-nitrophenyl)pyridine Chemical compound CC1=NC(C)=CC(C=2C(=CC=CC=2)[N+]([O-])=O)=C1 MXOZDWUWLZHSFP-UHFFFAOYSA-N 0.000 claims 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 12
- 241000187747 Streptomyces Species 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 2
- RMZQSAMHIQBMLW-UHFFFAOYSA-N 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid Chemical compound OC(=O)C1=C(C)NC(C)=C(C(O)=O)C1C1=CC=CC=C1[N+]([O-])=O RMZQSAMHIQBMLW-UHFFFAOYSA-N 0.000 abstract 1
- 241000223600 Alternaria Species 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 241000371644 Curvularia ravenelii Species 0.000 abstract 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 150000002148 esters Chemical group 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- HFFBRLXQWQCDEX-UHFFFAOYSA-N 1-hydroxy-2h-pyridin-4-ol Chemical compound ON1CC=C(O)C=C1 HFFBRLXQWQCDEX-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 241000187180 Streptomyces sp. Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- RZTAMFZIAATZDJ-UHFFFAOYSA-N felodipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012746 preparative thin layer chromatography Methods 0.000 description 2
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical compound OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical group CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- QHOWYOKUKZPTPL-KVVVOXFISA-N (z)-octadec-9-enoic acid;potassium Chemical compound [K].CCCCCCCC\C=C/CCCCCCCC(O)=O QHOWYOKUKZPTPL-KVVVOXFISA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- OHEKHNZMCAMZNU-UHFFFAOYSA-N 2-(3-nitrophenyl)pyridine Chemical compound [O-][N+](=O)C1=CC=CC(C=2N=CC=CC=2)=C1 OHEKHNZMCAMZNU-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- AFVBDOPDKXFXTN-UHFFFAOYSA-N 4-(3-nitrophenyl)pyridine Chemical compound [O-][N+](=O)C1=CC=CC(C=2C=CN=CC=2)=C1 AFVBDOPDKXFXTN-UHFFFAOYSA-N 0.000 description 1
- BLFRQYKZFKYQLO-UHFFFAOYSA-N 4-aminobutan-1-ol Chemical class NCCCCO BLFRQYKZFKYQLO-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 241001558165 Alternaria sp. Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000001729 Ammonium fumarate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 101710128742 Cytochrome b6-f complex iron-sulfur subunit 2 Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical class NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- GMKMEZVLHJARHF-WHFBIAKZSA-N LL-2,6-diaminopimelic acid Chemical compound OC(=O)[C@@H](N)CCC[C@H](N)C(O)=O GMKMEZVLHJARHF-WHFBIAKZSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical class [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- PVCJKHHOXFKFRP-UHFFFAOYSA-N N-acetylethanolamine Chemical compound CC(=O)NCCO PVCJKHHOXFKFRP-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000948169 Streptomyces viridosporus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000019297 ammonium fumarate Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- CKKXWJDFFQPBQL-SEPHDYHBSA-N azane;(e)-but-2-enedioic acid Chemical compound N.N.OC(=O)\C=C\C(O)=O CKKXWJDFFQPBQL-SEPHDYHBSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical group [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical group 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Chemical class 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Chemical group CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Substances [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940043274 prophylactic drug Drugs 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical group OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- XMVJITFPVVRMHC-UHFFFAOYSA-N roxarsone Chemical group OC1=CC=C([As](O)(O)=O)C=C1[N+]([O-])=O XMVJITFPVVRMHC-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
Definitions
- the present invention relates to an intermediate for producing an optically active 1,4-dihydroxypyridine derivative which is useful as a prophylactic or therapeutic drug for ischemic heart disease or hypertension, and a method for producing the same.
- the method of Achinami et al uses a dihydroxypyridin ester derivative having a pivaloyloxymethyl group bonded to the 3rd and 5th positions of the dihydroxypyridin ring as a substrate. And enzymatic asymmetric hydrolysis of one ester to induce optically active dihydroxypyridinone monocarboxylic acid as an intermediate for the synthesis of pharmaceuticals It is guided to a conductor.
- this method requires many steps until the synthesis of the substrate and the conversion of the bivaloyloxymethyl group, etc., to other substituents, leading to compounds useful as pharmaceuticals.
- Sih et al. Is essentially the same as that of Achinami et al., Except that vivaloyl methoxymethyl ester is replaced by acetoximetyl ester.
- the present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, by using microorganisms, (4R) _1, 4—dihydroxypyridine_3, The present inventors have found a method for efficiently producing a 5—dica renoic acid monoester derivative, and have completed the present invention.
- R is a lower alkanol group, a heterocyclic carbyl group, a halo-substituted acetyl group, an alkoxy acetyl group, an aryloxy acetyl group, a substituted or unsubstituted group
- n represents an integer of 2 to 4.
- An object of the present invention is to provide a method for producing a monoester derivative.
- R ' represents a lower alkanol group, and n represents an integer of 2 to 4). Or a salt thereof.
- R is a formyl group, an acetyl group, a propionyl group, a butyryl group, an isobutylinole group, a phenol group.
- Lower alkanol groups such as phenolic groups, isovaleryl groups, picolinol groups, nicotinyl groups, isonicotinyl groups, and nicotine groups Heterocyclic carbonyl groups such as phenyl group, quinolinyl group, quinoxanol group, and phenethyl group; trifluoroacetyl group, chloroacetyl group, diacetyl group H-substituted acetyl groups such as loroacetyl group, trichloroacetyl group, bromoacetyl group, molybdenum moacetyl group; alkoxyacetyl groups such as methoxy cetyl group and ethoxy cetyl group.
- an alkenyloxycarbonyl group an alkaryloxycarbonyl group such as a benzyloxycarbonyl group; a methanesulfonyl group, a benzenesulfonyl group, a benzylsulfonyl group, and a treensulfonyl group And organic sulfonyl groups.
- the position of substitution of the nitro group on the phenyl group at the 4-position is not limited, and may be any of the 2-, 3- and 4-positions.
- the starting material of the formula (I) used in the production method by the microbial reaction of the present invention can also be used as a salt.
- salts include organic acid addition salts such as acetic acid, tartaric acid, and benzenesulfonic acid; and inorganic acid addition salts such as hydrochloric acid and sulfuric acid.
- the starting material represented by the formula (I) can be produced by a method known per se. That is, the following equation (V)
- R is a lower alkanol group, a heterocyclic carbonyl group, a peroxysubstituted acetyl group, an alkoxyacetyl group, an aryloxy acetyl group, a substituted or unsubstituted phenyl group
- the present invention relates to a compound which can be suitably used as a raw material compound for the production method by the above-mentioned microbial reaction, wherein R in formula (I) is a lower alkanol group, Formula (H) HR '
- R ′ represents a lower alkanol group, and n represents an integer of 2 to 4). It is.
- the present invention provides a compound represented by the following formula, which is produced by subjecting a compound of the above formula (II) or a salt thereof to a production method by the above microbial reaction.
- the present invention also provides a novel optically active 1,4-dihydroxypyridine compound or a salt thereof.
- Microorganisms used in the above microbial reaction include Streptomics spp., Paschicum spp., Botryodipopia spp., Altenaria spp. Or Helmint. Microorganisms having asymmetric hydrolytic ability belonging to the genus Sporium can be used. Examples of such microorganisms include FI-4 strains, FI-741 strains, FI-107 strains, and A-914 strains. The morphological characteristics of these bacteria are shown below.
- a pale gray-white flocculent mycelium layer is formed on the potato dextroth agar medium, and as the culture proceeds, the base becomes black-grey.
- the conidium is a polo-type condensed thread that emerges from a small hole at the top of the conidiophore, and is divided by partition walls and has a shape with piles. The bottom of the conidia is round, the top is sharp and the color is brown.
- a well-developed white cotton-like mycelium layer is formed on a potato dextroth agar medium, and the base turns brown as the culture proceeds.
- Conidia are formed in spherical organs called conidial shells with open apical tips. Conidia are rather long, smooth and non-viscous. As it matures it becomes brown and the cell wall becomes thicker.
- a gray-white mycelium layer is formed on the potato dextroth agar medium, and as the culture proceeds, the base becomes a slightly pink brown color.
- the conidium is the most advanced branch on the conidiophore. This is a file type that emerges from the file type. The conidium stalks are rarely divided, but the fly-rides are well divided and have an elongated structure.
- FI-14 was found to be Alternaria sp.
- FI — 741 is for Botryodi oplodia sp.
- F I — 107 is the name of Mrs. Sp.
- the cell wall component contains L-diaminopimelic acid.
- L Hydroxyproline is not available. Sensitive to 1000 ⁇ g / m1 ore.
- A-914 was identified as Streptomyces viri dosporus.
- the FI-4 shares were deposited with the Institute of Life Science and Industrial Technology, Institute of Industrial Science and Technology on March 18, 1993, and were assigned the accession number FERMP-135335. Later, on June 14, 1993, the deposit was transferred to a deposit based on the Budapest Treaty, and the deposit number was assigned as FERMBP — 4335.
- FI-741 shares, FI-107 and A-914 shares were respectively deposited at the Institute of Biotechnology and Industrial Technology, Institute of Industrial Science and Technology on July 29, 1992, and were commissioned.
- FERM as a number
- microorganisms examples include Streptomyces sp. ATC C1862 and Helmintosporizonatanum IF66678. These microorganisms are stored in the American Type Culture Collection and the Fermentation Research Institute, respectively, and are readily available.
- the medium for culturing the microorganism is not particularly limited, and may be any medium that can be used for culturing a normal microorganism.
- any of the above microorganisms can be used as a carbon source, such as glucose, fructose, sucrose, dextrin, etc.
- Sugars; Sugar alcohols such as cellulose and sorbitol; organic acids such as fumaric acid and citric acid can be used.
- the amount of these carbon sources to be added to the medium is usually preferably about 0.1 to 10%.
- Cultivation of the microorganisms is performed under aerobic conditions at 20 to 40 ° C., preferably 28 to 37 ° C., pH 5 to 9, preferably 6 to 8 in the above medium. It is sufficient to carry out.
- the microbial reaction is carried out by reacting with a microorganism or a processed product thereof.
- the reaction with the microorganism is usually a reaction with a culture of the microorganism, and the culture of the microorganism includes the cultured microorganism cells, culture filtrate, and culture solution.
- the processed microorganism is a microorganism that has been cultured.
- Processed products such as processed products, culture filtrates and culture solutions, and processed products of the microbial cells include dried cells, for example, freeze-dried cells, spray-dried cells, or organic solvents, for example, Bacteria treated with seton, toluene, methanol, butanol, etc., cell extracts, and immobilized products can be mentioned.
- the microorganism is inoculated into the medium at a temperature of 20 to 40 ° C. for 12 to 120 hours after inoculating the microorganism with the medium. 6 to 1 0 1.
- the compound of the formula (I) which is the starting compound, is dissolved in water or a solubilizing agent so as to have a final concentration of 0.5 mgZml to 5 mgZml and added to the culture solution. And react for 18 to 72 hours.
- organic solvents can be used as the solubilizing agent used here.
- organic solvents include acetone, 'methylethylketone, dimethylsulfoxide, dioxane, N, N-dimethylformamide, acetonitril, and the like. These can be used alone or in combination Or more.
- the addition amount is preferably in the range of 3 to 5% based on the medium.
- Streptomyces pyridosporus A—914 was added to 30 ml of C medium (potato starch 2%, essanmeat 2%, yeast extract 0.5%, NaCl 0.25% CaC0 3 0. 3 2%, FeS0 4 7 H 2 0 0.00 0 5%, MnS0 4 4 H 2 0 0.00 0 5%, ZnS0 4 7 H 2 0 0.00 0 5%, pH7. 2 5 0 m including 4)
- C medium potato starch 2%, essanmeat 2%, yeast extract 0.5%, NaCl 0.25% CaC0 3 0. 3 2%, FeS0 4 7 H 2 0 0.00 0 5%, MnS0 4 4 H 2 0 0.00 0 5%, ZnS0 4 7 H 2 0 0.00 0 5%, pH7. 2 5 0 m including 4)
- C medium potato starch 2%, essanmeat 2%, yeast extract
- 1,4-Dihydro-2,6 dimethyl-41- (3-di-torophenyl) pyridin-1,3,5—bis (2-dicarboxylate)
- 60 mg of (chinoaminoethyl) ester'2 hydrochloride was dissolved in 0.75 ml of distilled water, and the mixture was further shaken at 28 ° C for 2 days.
- 1N hydrochloric acid was added to the reaction mixture to adjust the pH to 5.0, and the mixture was extracted with 30 ml of ethyl acetate. The organic layer was separated and back-extracted with a 0.1 N aqueous sodium hydroxide solution (20 mix 3).
- optical purity of this substance was determined using a column for chiral AGP (4 mm x 100 mm) manufactured by Daicel Industries, Ltd., using HPLC (mobile phase; 0.6% isoprono, The analysis was carried out using 0.1 M phosphate buffer (pH 7.1), flow rate: 0.7 mlZmin]. As a result, the optical purity was 100%, and the retention time was 4.7 minutes.
- the reaction was carried out in the same manner as in Example 1-3) using the Altenaria SP FI-4 and Hermintosporizon zonatum IF-6678, and analyzed by TLC. Then, the desired monocarboxylic acid was confirmed.
- 1,4-Dihydro-2,6 dimethyl—4— (3—ditrophenyl) pyridin-3,5—bis dicarboxylate (2—) 60 mg of acetamidoethyl) ester was dissolved in 0.75 ml of dimethyl sulfoxide, and the mixture was further shaken at 28 ° C for 2 days. Add IN to this reaction mixture. Hydrochloric acid was added to adjust the pH to 3.0, and extracted with 3 Oml of ethyl acetate.
- This organic phase was back-extracted with 20 ml of 0.1 M sodium hydroxide. After adjusting the pH of the extract to 3.0, the extract was extracted with 20 ml of ethyl acetate, washed with saturated saline, and dried over anhydrous sodium sulfate. After concentrating the organic phase, adsorb it onto a preparative TLC plate, develop it with a black hole form: methanol (7: 1), and exhibit UV absorption at an R f value of 0.22 The eluted fraction was evaporated to dryness under reduced pressure to obtain 10 mg of the desired title compound.
- optical purity of this substance was determined by HPLC using a chiral AGP (4 mm XIOO mra), a chiral AGP (4 mm XIOO mra) manufactured by Daicel Industries, Ltd., with a mobile phase of 0.35% isopro phenol.
- the analysis was carried out using a phosphate buffer (PH4.4) and a flow rate of 0.8 ml Zmi ⁇ ]. As a result, the optical purity was 100%, and the retention time was 14.3 minutes.
- the (R) -body preparation of the title compound is produced as follows. That is, it was prepared according to the method described by Shibanuma et al. [Chem. Pharm. Bull., Vol. 28 (9), 280-9 — 2812 (1980)]. ) — (+) — 1, 4 — Dihydro ⁇ — 2, 6 — Dimethyl 5 — Methoxycarbinol 4 1 (3 — Nitrophenyl) 1 3 — Pyridin After dissolving 5 mg of potassium oleic acid in 0.5 ml of tetrahydrofuran, add 2-1 of isobutyl chloroformate, stir for 10 minutes, and then add triethylamine 6-1. And N-acetylamine 30 p.
- 1,2-Dihydro-2,6-dimethyl-41- (3-diphenyl) pyridin-1,3,5-dicanoleponic acid is added to each 2 ml of the obtained culture solution.
- Bis (2-acetamidoethyl) ester 4 mg of dimethyl sulfoxide solution (50 ⁇ 1) was added, and the mixture was further shaken at 28 ° C for 2 days.
- the reaction mixture was adjusted to pH 3.0 with 1N hydrochloric acid, and extracted with ethyl acetate. From the obtained organic layer, 0.5 mg of the desired optically active monocarboxylic acid was obtained.
- Helmint sporadion zonatum F ⁇ 6 6 7 8 and bottle audio DIA sp. F 1 — 7 4 1 were each added to FI medium (potato starter 2%, Esusa emissions Mi over preparative 2%, KH 2 P0 4 0. 1%, MgS0 4 7 H 2 0 0.05%, Group courses 1%, explanted bacteria Adeka Roh Nore LG 1 0 9 0. 0 5% ) The cells were cultured at 28 ° C for 3 days.
- the compound represented by the general formula (I) or a salt thereof, which is simple and has high optical purity, is provided by the process for producing a fine substance according to the present invention.
- optically active 1,4-dihydroxypyridin derivatives such as (4R)-(2—nicotinoylamino) ethyl (I) are effective for diseases such as ischemic disease and hypertension.
- 3-nitro) Propyl 1, 4-dihydro 2 6-dimethyl 1 4-(3-nitrophenyl) pyridin 1, 3-5-dicanolevo The production efficiency of Xylate ["Takahashi et al., Jpn. J. Pharmacol., Vol 58, Suppl. I, p399 (1992)"] etc. is achieved.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69330130T DE69330130T2 (de) | 1992-08-31 | 1993-08-31 | Verfahren zur herstellung von optisch aktiven 1,4-dihydropyridinen |
KR1019950700567A KR100244728B1 (ko) | 1992-08-31 | 1993-08-31 | 광학활성 1,4-디히드로피리딘 화합물 및 그의 제조방법 |
AT93919593T ATE200484T1 (de) | 1992-08-31 | 1993-08-31 | Verfahren zur herstellung von optisch aktiven 1,4-dihydropyridinen |
AU49818/93A AU4981893A (en) | 1992-08-31 | 1993-08-31 | Optically active 1,4-dihydropyridine compound and process for producing the same |
US08/387,750 US5635395A (en) | 1992-08-31 | 1993-08-31 | Optically active 1,4-dihydropyridine compounds and the microbial process for the stereoselection thereof |
EP93919593A EP0657429B1 (en) | 1992-08-31 | 1993-08-31 | Process for production of optically active 1,4-dihydropyridine compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23187792 | 1992-08-31 | ||
JP4/231877 | 1992-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994005637A1 true WO1994005637A1 (en) | 1994-03-17 |
Family
ID=16930427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1993/001222 WO1994005637A1 (en) | 1992-08-31 | 1993-08-31 | Optically active 1,4-dihydropyridine compound and process for producing the same |
Country Status (8)
Country | Link |
---|---|
US (1) | US5635395A (ja) |
EP (1) | EP0657429B1 (ja) |
KR (1) | KR100244728B1 (ja) |
AT (1) | ATE200484T1 (ja) |
AU (1) | AU4981893A (ja) |
CA (1) | CA2143106A1 (ja) |
DE (1) | DE69330130T2 (ja) |
WO (1) | WO1994005637A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996006829A1 (fr) * | 1994-08-29 | 1996-03-07 | Mercian Corporation | Derive de 1,4-dihydropyrydine |
US6143541A (en) * | 1995-07-31 | 2000-11-07 | Mercian Corporation | Gene encoding a protein having symmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives and its expression product |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0985667A4 (en) * | 1997-04-25 | 2000-03-22 | Ajinomoto Kk | NEW DIHYDROPYRIDINE DERIVATIVE |
US6145143A (en) * | 1999-06-03 | 2000-11-14 | Kinetic Concepts, Inc. | Patient support systems with layered fluid support mediums |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6460398A (en) * | 1987-08-28 | 1989-03-07 | Chisso Corp | Production of optically active compound having pyridine skeleton |
JPH04299994A (ja) * | 1991-03-26 | 1992-10-23 | Taisho Pharmaceut Co Ltd | 光学活性1,4−ジヒドロピリジン化合物の製造法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4656181A (en) * | 1982-11-24 | 1987-04-07 | Cermol S.A. | Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same |
JPH0641075A (ja) * | 1990-09-01 | 1994-02-15 | Kazuo Achinami | 新規な1,4−ジヒドロピリジン化合物及びその製造方法 |
US5234821A (en) * | 1990-09-01 | 1993-08-10 | Kazuo Achiwa | Process for preparing 1,4 dihydropyridine compounds |
US5100892A (en) * | 1990-11-13 | 1992-03-31 | Glaxo Inc. | Dihydropyridine vasodilator agents |
JPH0584089A (ja) * | 1991-03-01 | 1993-04-06 | Taisho Pharmaceut Co Ltd | 光学活性1,4−ジヒドロピリジン化合物の製造法 |
JP3286645B2 (ja) * | 1993-03-26 | 2002-05-27 | メルシャン株式会社 | 光学活性1,4−ジヒドロピリジン誘導体およびその製造方法 |
-
1993
- 1993-08-31 US US08/387,750 patent/US5635395A/en not_active Expired - Fee Related
- 1993-08-31 AU AU49818/93A patent/AU4981893A/en not_active Abandoned
- 1993-08-31 WO PCT/JP1993/001222 patent/WO1994005637A1/ja active IP Right Grant
- 1993-08-31 CA CA002143106A patent/CA2143106A1/en not_active Abandoned
- 1993-08-31 KR KR1019950700567A patent/KR100244728B1/ko not_active IP Right Cessation
- 1993-08-31 DE DE69330130T patent/DE69330130T2/de not_active Expired - Fee Related
- 1993-08-31 EP EP93919593A patent/EP0657429B1/en not_active Expired - Lifetime
- 1993-08-31 AT AT93919593T patent/ATE200484T1/de active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6460398A (en) * | 1987-08-28 | 1989-03-07 | Chisso Corp | Production of optically active compound having pyridine skeleton |
JPH04299994A (ja) * | 1991-03-26 | 1992-10-23 | Taisho Pharmaceut Co Ltd | 光学活性1,4−ジヒドロピリジン化合物の製造法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996006829A1 (fr) * | 1994-08-29 | 1996-03-07 | Mercian Corporation | Derive de 1,4-dihydropyrydine |
EP0779277A1 (en) * | 1994-08-29 | 1997-06-18 | Mercian Corporation | 1,4-dihydropyridine derivative |
EP0779277A4 (en) * | 1994-08-29 | 1999-03-03 | Mercian Corp | 1,4-DIHYDROPYRYDINE DERIVATIVE |
CN1089337C (zh) * | 1994-08-29 | 2002-08-21 | 美而香株式会社 | 1,4-二氢吡啶衍生物 |
US6143541A (en) * | 1995-07-31 | 2000-11-07 | Mercian Corporation | Gene encoding a protein having symmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives and its expression product |
US6361987B1 (en) | 1995-07-31 | 2002-03-26 | Mercian Corporation | Gene encoding a protein having asymmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives and its expression product |
Also Published As
Publication number | Publication date |
---|---|
KR100244728B1 (ko) | 2000-03-02 |
AU4981893A (en) | 1994-03-29 |
DE69330130D1 (de) | 2001-05-17 |
ATE200484T1 (de) | 2001-04-15 |
CA2143106A1 (en) | 1994-03-17 |
EP0657429B1 (en) | 2001-04-11 |
EP0657429A4 (en) | 1996-03-27 |
EP0657429A1 (en) | 1995-06-14 |
DE69330130T2 (de) | 2001-08-02 |
US5635395A (en) | 1997-06-03 |
KR950702963A (ko) | 1995-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6034107A (en) | 5-Substituted picolinic acid compounds and their production process | |
CA2713009A1 (en) | ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof | |
JP3476860B2 (ja) | 3,5−ジオキソエステルの立体選択性微生物的または酵素的還元による3−ヒドロキシ−5−オキソ、3−オキソ−5−ヒドロキシおよび3,5−ジヒドロキシエステルの製造 | |
US5770438A (en) | Process for enantioselective hydrolysis of α-(2-amino)-phenyl-benzenemethanol ester type compounds using bacillus, pseudomonas or streptomyces | |
WO1994005637A1 (en) | Optically active 1,4-dihydropyridine compound and process for producing the same | |
EP0779277B1 (en) | 1,4-dihydropyridine derivative | |
US4743555A (en) | Biologically pure culture of Streptomyces sandaensis No. 6897 | |
JP2648472B2 (ja) | β−ラクタム化合物及びその製造方法 | |
AU775861B2 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives | |
EP0599967B1 (en) | Arylalkanoic acid resolution | |
US5395941A (en) | Optically active 1,4-hydropyridine compounds | |
Tarui et al. | Kinetic resolution of an indan derivative using Bacillus sp. SUI-12: Synthesis of a key intermediate of the melatonin receptor agonist TAK-375 | |
JPH0638776A (ja) | (S)−γ−ハロゲン化−β−ハイドロキシ酪酸エステルの製造方法 | |
US6416979B1 (en) | 5-substituted picolinic acid compounds production by Marasmiellus sp | |
US5559017A (en) | Microbial reduction of benzazepines and benzothiazepine derivatives | |
JPH06319593A (ja) | 光学活性1,4−ジヒドロピリジン化合物の製造方法 | |
JP3860639B2 (ja) | 光学活性化合物の製造法 | |
KR970001001B1 (ko) | I-디옥시만노딜리마이신의 제법 | |
CA2116108A1 (en) | Chiral gultarate esters, their resolution and derived glutarimide compounds | |
JPH04299994A (ja) | 光学活性1,4−ジヒドロピリジン化合物の製造法 | |
WO1994004701A1 (en) | Process for producing optically active 1,4-dihydropyridine compound | |
JPH0690790A (ja) | 光学活性1,4−ジヒドロピリジン−3,5−ジカルボン酸・モノエステル誘導体の製造方法 | |
WO1999007873A1 (de) | VERFAHREN ZUR HERSTELLUNG ENANTIOMERENREINER CYCLISCHER α-AMINOSÄUREN BZW. DEREN N-GESCHÜTZTER DERIVATE MITTELS EINER D-SPEZIFISCHEN AMINOACYLASE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 08387750 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2143106 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993919593 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993919593 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1993919593 Country of ref document: EP |